
### [MONDO:0000636](http://purl.obolibrary.org/obo/MONDO_0000636)
**Label:** musculoskeletal system benign neoplasm

**Subclasses:** [MONDO:0008145](http://purl.obolibrary.org/obo/MONDO_0008145) (Ollier disease), [MONDO:0000938](http://purl.obolibrary.org/obo/MONDO_0000938) (gastric leiomyoma), [MONDO:0003925](http://purl.obolibrary.org/obo/MONDO_0003925) (ethmoid sinus inverted papilloma), [MONDO:0002318](http://purl.obolibrary.org/obo/MONDO_0002318) (trachea leiomyoma), [MONDO:0001745](http://purl.obolibrary.org/obo/MONDO_0001745) (subserous uterine fibroid), [MONDO:0003923](http://purl.obolibrary.org/obo/MONDO_0003923) (ethmoid sinus Schneiderian papilloma), [MONDO:0021477](http://purl.obolibrary.org/obo/MONDO_0021477) (benign neoplasm of sphenoidal sinus), [MONDO:0000934](http://purl.obolibrary.org/obo/MONDO_0000934) (laryngeal leiomyoma), [MONDO:0021515](http://purl.obolibrary.org/obo/MONDO_0021515) (benign neoplasm of ethmoidal sinus), [MONDO:0002712](http://purl.obolibrary.org/obo/MONDO_0002712) (epidural spinal canal angiolipoma), [MONDO:0000654](http://purl.obolibrary.org/obo/MONDO_0000654) (connective tissue benign neoplasm), [MONDO:0003887](http://purl.obolibrary.org/obo/MONDO_0003887) (ovarian mucinous adenofibroma), [MONDO:0004214](http://purl.obolibrary.org/obo/MONDO_0004214) (ovarian endometrioid cystadenofibroma), [MONDO:0006634](http://purl.obolibrary.org/obo/MONDO_0006634) (pituitary gland acidophil adenoma), [MONDO:0004457](http://purl.obolibrary.org/obo/MONDO_0004457) (maxillary sinus Schneiderian papilloma), [MONDO:0006238](http://purl.obolibrary.org/obo/MONDO_0006238) (growth hormone-producing pituitary gland adenoma), [MONDO:0002399](http://purl.obolibrary.org/obo/MONDO_0002399) (nodular tenosynovitis), [MONDO:0006353](http://purl.obolibrary.org/obo/MONDO_0006353) (paranasal sinus Schneiderian papilloma), [MONDO:0018907](http://purl.obolibrary.org/obo/MONDO_0018907) (craniopharyngioma), [MONDO:0010621](http://purl.obolibrary.org/obo/MONDO_0010621) (child syndrome), [MONDO:0021509](http://purl.obolibrary.org/obo/MONDO_0021509) (benign neoplasm of myocardium), [MONDO:0016035](http://purl.obolibrary.org/obo/MONDO_0016035) (Nelson syndrome), [MONDO:0009227](http://purl.obolibrary.org/obo/MONDO_0009227) (myofibromatosis, infantile, 1), [MONDO:0001634](http://purl.obolibrary.org/obo/MONDO_0001634) (bladder leiomyoma), [MONDO:0006646](http://purl.obolibrary.org/obo/MONDO_0006646) (angioleiomyoma), [MONDO:0004501](http://purl.obolibrary.org/obo/MONDO_0004501) (fallopian tube cystadenofibroma), [MONDO:0004185](http://purl.obolibrary.org/obo/MONDO_0004185) (ovarian serous cystadenofibroma), [MONDO:0007052](http://purl.obolibrary.org/obo/MONDO_0007052) (growth hormone secreting pituitary adenoma), [MONDO:0019933](http://purl.obolibrary.org/obo/MONDO_0019933) (acromegaly), [MONDO:0018447](http://purl.obolibrary.org/obo/MONDO_0018447) (chondromyxoid fibroma), [MONDO:0014122](http://purl.obolibrary.org/obo/MONDO_0014122) (myofibromatosis, infantile, 2), [MONDO:0000513](http://purl.obolibrary.org/obo/MONDO_0000513) (bone ameloblastoma), [MONDO:0002934](http://purl.obolibrary.org/obo/MONDO_0002934) (intravascular angioleiomyoma), [MONDO:0001845](http://purl.obolibrary.org/obo/MONDO_0001845) (uterine corpus lipoleiomyoma), [MONDO:0001844](http://purl.obolibrary.org/obo/MONDO_0001844) (uterine corpus myxoid leiomyoma), [MONDO:0021456](http://purl.obolibrary.org/obo/MONDO_0021456) (benign neoplasm of sternum), [MONDO:0000516](http://purl.obolibrary.org/obo/MONDO_0000516) (phalanx chondroma), [MONDO:0001846](http://purl.obolibrary.org/obo/MONDO_0001846) (uterine corpus bizarre leiomyoma), [MONDO:0001841](http://purl.obolibrary.org/obo/MONDO_0001841) (uterine corpus epithelioid leiomyoma), [MONDO:0000631](http://purl.obolibrary.org/obo/MONDO_0000631) (bone benign neoplasm), [MONDO:0004832](http://purl.obolibrary.org/obo/MONDO_0004832) (esophagus leiomyoma), [MONDO:0001843](http://purl.obolibrary.org/obo/MONDO_0001843) (uterus interstitial leiomyoma), [MONDO:0001842](http://purl.obolibrary.org/obo/MONDO_0001842) (uterine corpus dissecting leiomyoma), [MONDO:0003980](http://purl.obolibrary.org/obo/MONDO_0003980) (schwannoma of jugular foramen), [MONDO:0006179](http://purl.obolibrary.org/obo/MONDO_0006179) (desmoplastic ameloblastoma), [MONDO:0003461](http://purl.obolibrary.org/obo/MONDO_0003461) (fallopian tube adenofibroma), [MONDO:0003061](http://purl.obolibrary.org/obo/MONDO_0003061) (benign muscle neoplasm), [MONDO:0002092](http://purl.obolibrary.org/obo/MONDO_0002092) (small intestine leiomyoma), [MONDO:0007660](http://purl.obolibrary.org/obo/MONDO_0007660) (familial ossifying fibroma), [MONDO:0016824](http://purl.obolibrary.org/obo/MONDO_0016824) (myofibromatosis), [MONDO:0012691](http://purl.obolibrary.org/obo/MONDO_0012691) (leopard syndrome 2), [MONDO:0013380](http://purl.obolibrary.org/obo/MONDO_0013380) (leopard syndrome 3), [MONDO:0002787](http://purl.obolibrary.org/obo/MONDO_0002787) (adamantinous craniopharyngioma), [MONDO:0020479](http://purl.obolibrary.org/obo/MONDO_0020479) (pituitary gigantism), [MONDO:0004326](http://purl.obolibrary.org/obo/MONDO_0004326) (sphenoid sinus inverted papilloma), [MONDO:0004327](http://purl.obolibrary.org/obo/MONDO_0004327) (sphenoid sinus Schneiderian papilloma), [MONDO:0004448](http://purl.obolibrary.org/obo/MONDO_0004448) (frontal sinus inverted papilloma), [MONDO:0004723](http://purl.obolibrary.org/obo/MONDO_0004723) (liver leiomyoma), [MONDO:0002788](http://purl.obolibrary.org/obo/MONDO_0002788) (papillary craniopharyngioma), [MONDO:0003752](http://purl.obolibrary.org/obo/MONDO_0003752) (frontal sinus Schneiderian papilloma), [MONDO:0001572](http://purl.obolibrary.org/obo/MONDO_0001572) (leiomyoma), [MONDO:0006106](http://purl.obolibrary.org/obo/MONDO_0006106) (benign smooth muscle neoplasm), [MONDO:0006068](http://purl.obolibrary.org/obo/MONDO_0006068) (ACTH-producing pituitary gland adenoma), [MONDO:0002780](http://purl.obolibrary.org/obo/MONDO_0002780) (extraskeletal chondroma), [MONDO:0004162](http://purl.obolibrary.org/obo/MONDO_0004162) (uterine corpus cellular leiomyoma), [MONDO:0006340](http://purl.obolibrary.org/obo/MONDO_0006340) (ovarian serous adenofibroma), [MONDO:0004161](http://purl.obolibrary.org/obo/MONDO_0004161) (uterine corpus apoplectic leiomyoma), [MONDO:0006183](http://purl.obolibrary.org/obo/MONDO_0006183) (disseminated peritoneal leiomyomatosis), [MONDO:0019927](http://purl.obolibrary.org/obo/MONDO_0019927) (growth hormone-producing pituitary gland neoplasm), [MONDO:0009050](http://purl.obolibrary.org/obo/MONDO_0009050) (ACTH-secreting pituitary adenoma), [MONDO:0002119](http://purl.obolibrary.org/obo/MONDO_0002119) (ossifying fibroma (disease)), [MONDO:0001664](http://purl.obolibrary.org/obo/MONDO_0001664) (submucous uterine fibroid), [MONDO:0002359](http://purl.obolibrary.org/obo/MONDO_0002359) (juxtacortical chondroma), [MONDO:0003289](http://purl.obolibrary.org/obo/MONDO_0003289) (deep leiomyoma), [MONDO:0003288](http://purl.obolibrary.org/obo/MONDO_0003288) (bizarre leiomyoma), [MONDO:0007886](http://purl.obolibrary.org/obo/MONDO_0007886) (uterine corpus leiomyoma), [MONDO:0006312](http://purl.obolibrary.org/obo/MONDO_0006312) (myofibroma), [MONDO:0003285](http://purl.obolibrary.org/obo/MONDO_0003285) (fallopian tube leiomyoma), [MONDO:0004133](http://purl.obolibrary.org/obo/MONDO_0004133) (pituitary gland mixed eosinophil-basophil adenoma), [MONDO:0003284](http://purl.obolibrary.org/obo/MONDO_0003284) (mediastinum leiomyoma), [MONDO:0021273](http://purl.obolibrary.org/obo/MONDO_0021273) (leiomyoma of ciliary body), [MONDO:0006673](http://purl.obolibrary.org/obo/MONDO_0006673) (pituitary gland basophil adenoma), [MONDO:0003287](http://purl.obolibrary.org/obo/MONDO_0003287) (central nervous system leiomyoma), [MONDO:0003286](http://purl.obolibrary.org/obo/MONDO_0003286) (extrahepatic bile duct leiomyoma), [MONDO:0002072](http://purl.obolibrary.org/obo/MONDO_0002072) (melanotic neuroectodermal tumor), [MONDO:0010492](http://purl.obolibrary.org/obo/MONDO_0010492) (pituitary adenoma, growth hormone-secreting, 2), [MONDO:0004705](http://purl.obolibrary.org/obo/MONDO_0004705) (liver fibroma), [MONDO:0021543](http://purl.obolibrary.org/obo/MONDO_0021543) (hemangioma of gingiva), [MONDO:0003613](http://purl.obolibrary.org/obo/MONDO_0003613) (diffuse peritoneal leiomyomatosis), [MONDO:0003614](http://purl.obolibrary.org/obo/MONDO_0003614) (intravenous leiomyomatosis), [MONDO:0003458](http://purl.obolibrary.org/obo/MONDO_0003458) (uterine corpus adenofibroma), [MONDO:0003299](http://purl.obolibrary.org/obo/MONDO_0003299) (colorectal leiomyoma), [MONDO:0001399](http://purl.obolibrary.org/obo/MONDO_0001399) (ureter leiomyoma), [MONDO:0003695](http://purl.obolibrary.org/obo/MONDO_0003695) (ovarian clear cell adenofibroma), [MONDO:0003296](http://purl.obolibrary.org/obo/MONDO_0003296) (cellular leiomyoma), [MONDO:0003694](http://purl.obolibrary.org/obo/MONDO_0003694) (ovarian clear cell cystadenofibroma), [MONDO:0003295](http://purl.obolibrary.org/obo/MONDO_0003295) (leiomyomatosis), [MONDO:0004384](http://purl.obolibrary.org/obo/MONDO_0004384) (maxillary sinus inverted papilloma), [MONDO:0003298](http://purl.obolibrary.org/obo/MONDO_0003298) (vulvar leiomyoma), [MONDO:0007893](http://purl.obolibrary.org/obo/MONDO_0007893) (Noonan syndrome with multiple lentigines), [MONDO:0003297](http://purl.obolibrary.org/obo/MONDO_0003297) (gallbladder leiomyoma), [MONDO:0003292](http://purl.obolibrary.org/obo/MONDO_0003292) (anus leiomyoma), [MONDO:0003291](http://purl.obolibrary.org/obo/MONDO_0003291) (leiomyoma cutis), [MONDO:0003294](http://purl.obolibrary.org/obo/MONDO_0003294) (pericardium leiomyoma), [MONDO:0003293](http://purl.obolibrary.org/obo/MONDO_0003293) (lung leiomyoma), [MONDO:0018936](http://purl.obolibrary.org/obo/MONDO_0018936) (osteoblastoma (disease)), [MONDO:0011744](http://purl.obolibrary.org/obo/MONDO_0011744) (primary intraosseous venous malformation), [MONDO:0019612](http://purl.obolibrary.org/obo/MONDO_0019612) (functioning gonadotropic adenoma), [MONDO:0019613](http://purl.obolibrary.org/obo/MONDO_0019613) (non-functioning pituitary adenoma), [MONDO:0019611](http://purl.obolibrary.org/obo/MONDO_0019611) (TSH-secreting pituitary adenoma), [MONDO:0003828](http://purl.obolibrary.org/obo/MONDO_0003828) (growth hormone-producing pituitary gland carcinoma), [MONDO:0017795](http://purl.obolibrary.org/obo/MONDO_0017795) (ameloblastoma), [MONDO:0021531](http://purl.obolibrary.org/obo/MONDO_0021531) (fibroma of lung), [MONDO:0008168](http://purl.obolibrary.org/obo/MONDO_0008168) (ovarian fibroma (disease)), [MONDO:0003703](http://purl.obolibrary.org/obo/MONDO_0003703) (uterine corpus leiomyomatosis), [MONDO:0021532](http://purl.obolibrary.org/obo/MONDO_0021532) (fibroma of prostate), [MONDO:0003429](http://purl.obolibrary.org/obo/MONDO_0003429) (functioning pituitary gland adenoma), [MONDO:0003704](http://purl.obolibrary.org/obo/MONDO_0003704) (uterine corpus diffuse leiomyomatosis), [MONDO:0003944](http://purl.obolibrary.org/obo/MONDO_0003944) (endobronchial leiomyoma), [MONDO:0003702](http://purl.obolibrary.org/obo/MONDO_0003702) (uterus intravascular leiomyomatosis), [MONDO:0004997](http://purl.obolibrary.org/obo/MONDO_0004997) (chondroblastoma (disease)), [MONDO:0003301](http://purl.obolibrary.org/obo/MONDO_0003301) (dartoic leiomyoma), [MONDO:0002057](http://purl.obolibrary.org/obo/MONDO_0002057) (breast leiomyoma), [MONDO:0002452](http://purl.obolibrary.org/obo/MONDO_0002452) (prostate leiomyoma), [MONDO:0021491](http://purl.obolibrary.org/obo/MONDO_0021491) (benign neoplasm of gum), [MONDO:0003300](http://purl.obolibrary.org/obo/MONDO_0003300) (appendix leiomyoma), [MONDO:0004076](http://purl.obolibrary.org/obo/MONDO_0004076) (tendon sheath lipoma), [MONDO:0005166](http://purl.obolibrary.org/obo/MONDO_0005166) (osteoma (disease)), [MONDO:0004077](http://purl.obolibrary.org/obo/MONDO_0004077) (lumbosacral lipoma), [MONDO:0004074](http://purl.obolibrary.org/obo/MONDO_0004074) (ovarian mucinous cystadenofibroma), [MONDO:0006373](http://purl.obolibrary.org/obo/MONDO_0006373) (pituitary gland adenoma), [MONDO:0017822](http://purl.obolibrary.org/obo/MONDO_0017822) (mixed functioning pituitary adenoma), [MONDO:0008154](http://purl.obolibrary.org/obo/MONDO_0008154) (osteomas of mandible), [MONDO:0003837](http://purl.obolibrary.org/obo/MONDO_0003837) (TSH producing pituitary tumor), [MONDO:0001536](http://purl.obolibrary.org/obo/MONDO_0001536) (vaginal leiomyoma), [MONDO:0021522](http://purl.obolibrary.org/obo/MONDO_0021522) (benign neoplasm of lower jaw bone), [MONDO:0003836](http://purl.obolibrary.org/obo/MONDO_0003836) (malignant thyroid stimulating hormone producing neoplasm of pituitary gland), [MONDO:0002222](http://purl.obolibrary.org/obo/MONDO_0002222) (urethra leiomyoma), [MONDO:0006701](http://purl.obolibrary.org/obo/MONDO_0006701) (chromophobe adenoma), [MONDO:0004006](http://purl.obolibrary.org/obo/MONDO_0004006) (rete ovarii cystadenofibroma), [MONDO:0004125](http://purl.obolibrary.org/obo/MONDO_0004125) (rectum leiomyoma), [MONDO:0009808](http://purl.obolibrary.org/obo/MONDO_0009808) (osteoid Osteoma (disease)), [MONDO:0021483](http://purl.obolibrary.org/obo/MONDO_0021483) (benign neoplasm of frontal sinus), [MONDO:0021484](http://purl.obolibrary.org/obo/MONDO_0021484) (benign neoplasm of maxillary sinus), [MONDO:0001092](http://purl.obolibrary.org/obo/MONDO_0001092) (colon leiomyoma), [MONDO:0004482](http://purl.obolibrary.org/obo/MONDO_0004482) (fibroosseous pseudotumor of digits), [MONDO:0017824](http://purl.obolibrary.org/obo/MONDO_0017824) (familial isolated pituitary adenoma), [MONDO:0006381](http://purl.obolibrary.org/obo/MONDO_0006381) (plexiform ameloblastoma), [MONDO:0010911](http://purl.obolibrary.org/obo/MONDO_0010911) (prolactin-producing pituitary gland adenoma), [MONDO:0017823](http://purl.obolibrary.org/obo/MONDO_0017823) (Somatomammotropinoma), [MONDO:0017826](http://purl.obolibrary.org/obo/MONDO_0017826) (null pituitary adenoma), [MONDO:0017825](http://purl.obolibrary.org/obo/MONDO_0017825) (silent pituitary adenoma), 

**Mapped go classes:** [GO:0060123](http://purl.obolibrary.org/obo/GO_0060123) (regulation of growth hormone secretion), [GO:0005070](http://purl.obolibrary.org/obo/GO_0005070) (SH3/SH2 adaptor activity), [GO:0006284](http://purl.obolibrary.org/obo/GO_0006284) (base-excision repair), [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0007010](http://purl.obolibrary.org/obo/GO_0007010) (cytoskeleton organization), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0060125](http://purl.obolibrary.org/obo/GO_0060125) (negative regulation of growth hormone secretion), [GO:0002244](http://purl.obolibrary.org/obo/GO_0002244) (hematopoietic progenitor cell differentiation), [GO:0045766](http://purl.obolibrary.org/obo/GO_0045766) (positive regulation of angiogenesis), [GO:0000187](http://purl.obolibrary.org/obo/GO_0000187) (activation of MAPK activity), [GO:0050793](http://purl.obolibrary.org/obo/GO_0050793) (regulation of developmental process), [GO:0000186](http://purl.obolibrary.org/obo/GO_0000186) (activation of MAPKK activity), [GO:0001942](http://purl.obolibrary.org/obo/GO_0001942) (hair follicle development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0072223](http://purl.obolibrary.org/obo/GO_0072223) (metanephric glomerular mesangium development), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0042383](http://purl.obolibrary.org/obo/GO_0042383) (sarcolemma), [GO:0019001](http://purl.obolibrary.org/obo/GO_0019001) (guanyl nucleotide binding), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0048806](http://purl.obolibrary.org/obo/GO_0048806) (genitalia development), [GO:0030261](http://purl.obolibrary.org/obo/GO_0030261) (chromosome condensation), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0048008](http://purl.obolibrary.org/obo/GO_0048008) (platelet-derived growth factor receptor signaling pathway), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043114](http://purl.obolibrary.org/obo/GO_0043114) (regulation of vascular permeability), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0048011](http://purl.obolibrary.org/obo/GO_0048011) (neurotrophin TRK receptor signaling pathway), [GO:0000077](http://purl.obolibrary.org/obo/GO_0000077) (DNA damage checkpoint), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0048015](http://purl.obolibrary.org/obo/GO_0048015) (phosphatidylinositol-mediated signaling), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0048013](http://purl.obolibrary.org/obo/GO_0048013) (ephrin receptor signaling pathway), [GO:0071364](http://purl.obolibrary.org/obo/GO_0071364) (cellular response to epidermal growth factor stimulus), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035265](http://purl.obolibrary.org/obo/GO_0035265) (organ growth), [GO:0035025](http://purl.obolibrary.org/obo/GO_0035025) (positive regulation of Rho protein signal transduction), [GO:0060020](http://purl.obolibrary.org/obo/GO_0060020) (Bergmann glial cell differentiation), [GO:0008203](http://purl.obolibrary.org/obo/GO_0008203) (cholesterol metabolic process), [GO:0006024](http://purl.obolibrary.org/obo/GO_0006024) (glycosaminoglycan biosynthetic process), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0008202](http://purl.obolibrary.org/obo/GO_0008202) (steroid metabolic process), [GO:0005057](http://purl.obolibrary.org/obo/GO_0005057) (signal transducer activity, downstream of receptor), [GO:0048259](http://purl.obolibrary.org/obo/GO_0048259) (regulation of receptor-mediated endocytosis), [GO:0038091](http://purl.obolibrary.org/obo/GO_0038091) (positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway), [GO:0048936](http://purl.obolibrary.org/obo/GO_0048936) (peripheral nervous system neuron axonogenesis), [GO:0060027](http://purl.obolibrary.org/obo/GO_0060027) (convergent extension involved in gastrulation), [GO:0060028](http://purl.obolibrary.org/obo/GO_0060028) (convergent extension involved in axis elongation), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:1990782](http://purl.obolibrary.org/obo/GO_1990782) (protein tyrosine kinase binding), [GO:0006935](http://purl.obolibrary.org/obo/GO_0006935) (chemotaxis), [GO:0007229](http://purl.obolibrary.org/obo/GO_0007229) (integrin-mediated signaling pathway), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0060947](http://purl.obolibrary.org/obo/GO_0060947) (cardiac vascular smooth muscle cell differentiation), [GO:0048146](http://purl.obolibrary.org/obo/GO_0048146) (positive regulation of fibroblast proliferation), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0051428](http://purl.obolibrary.org/obo/GO_0051428) (peptide hormone receptor binding), [GO:2000379](http://purl.obolibrary.org/obo/GO_2000379) (positive regulation of reactive oxygen species metabolic process), [GO:0031698](http://purl.obolibrary.org/obo/GO_0031698) (beta-2 adrenergic receptor binding), [GO:0048709](http://purl.obolibrary.org/obo/GO_0048709) (oligodendrocyte differentiation), [GO:0035255](http://purl.obolibrary.org/obo/GO_0035255) (ionotropic glutamate receptor binding), [GO:0016616](http://purl.obolibrary.org/obo/GO_0016616) (oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor), [GO:0061582](http://purl.obolibrary.org/obo/GO_0061582) (intestinal epithelial cell migration), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0046887](http://purl.obolibrary.org/obo/GO_0046887) (positive regulation of hormone secretion), [GO:0043254](http://purl.obolibrary.org/obo/GO_0043254) (regulation of protein complex assembly), [GO:0038085](http://purl.obolibrary.org/obo/GO_0038085) (vascular endothelial growth factor binding), [GO:0048705](http://purl.obolibrary.org/obo/GO_0048705) (skeletal system morphogenesis), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0046888](http://purl.obolibrary.org/obo/GO_0046888) (negative regulation of hormone secretion), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0033629](http://purl.obolibrary.org/obo/GO_0033629) (negative regulation of cell adhesion mediated by integrin), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0033628](http://purl.obolibrary.org/obo/GO_0033628) (regulation of cell adhesion mediated by integrin), [GO:0071260](http://purl.obolibrary.org/obo/GO_0071260) (cellular response to mechanical stimulus), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0051430](http://purl.obolibrary.org/obo/GO_0051430) (corticotropin-releasing hormone receptor 1 binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0031683](http://purl.obolibrary.org/obo/GO_0031683) (G-protein beta/gamma-subunit complex binding), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0098609](http://purl.obolibrary.org/obo/GO_0098609) (cell-cell adhesion), [GO:0036459](http://purl.obolibrary.org/obo/GO_0036459) (thiol-dependent ubiquitinyl hydrolase activity), [GO:0043548](http://purl.obolibrary.org/obo/GO_0043548) (phosphatidylinositol 3-kinase binding), [GO:0060441](http://purl.obolibrary.org/obo/GO_0060441) (epithelial tube branching involved in lung morphogenesis), [GO:0007173](http://purl.obolibrary.org/obo/GO_0007173) (epidermal growth factor receptor signaling pathway), [GO:0006641](http://purl.obolibrary.org/obo/GO_0006641) (triglyceride metabolic process), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0045840](http://purl.obolibrary.org/obo/GO_0045840) (positive regulation of mitotic nuclear division), [GO:0060325](http://purl.obolibrary.org/obo/GO_0060325) (face morphogenesis), [GO:0060326](http://purl.obolibrary.org/obo/GO_0060326) (cell chemotaxis), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0007606](http://purl.obolibrary.org/obo/GO_0007606) (sensory perception of chemical stimulus), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0003924](http://purl.obolibrary.org/obo/GO_0003924) (GTPase activity), [GO:0035633](http://purl.obolibrary.org/obo/GO_0035633) (maintenance of permeability of blood-brain barrier), [GO:0007186](http://purl.obolibrary.org/obo/GO_0007186) (G-protein coupled receptor signaling pathway), [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development), [GO:0000785](http://purl.obolibrary.org/obo/GO_0000785) (chromatin), [GO:0046825](http://purl.obolibrary.org/obo/GO_0046825) (regulation of protein export from nucleus), [GO:0003146](http://purl.obolibrary.org/obo/GO_0003146) (heart jogging), [GO:0050880](http://purl.obolibrary.org/obo/GO_0050880) (regulation of blood vessel size), [GO:0001878](http://purl.obolibrary.org/obo/GO_0001878) (response to yeast), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0043560](http://purl.obolibrary.org/obo/GO_0043560) (insulin receptor substrate binding), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0050768](http://purl.obolibrary.org/obo/GO_0050768) (negative regulation of neurogenesis), [GO:0030178](http://purl.obolibrary.org/obo/GO_0030178) (negative regulation of Wnt signaling pathway), [GO:0030971](http://purl.obolibrary.org/obo/GO_0030971) (receptor tyrosine kinase binding), [GO:0016324](http://purl.obolibrary.org/obo/GO_0016324) (apical plasma membrane), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:2001275](http://purl.obolibrary.org/obo/GO_2001275) (positive regulation of glucose import in response to insulin stimulus), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance), [GO:0021697](http://purl.obolibrary.org/obo/GO_0021697) (cerebellar cortex formation), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0001840](http://purl.obolibrary.org/obo/GO_0001840) (neural plate development), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0047012](http://purl.obolibrary.org/obo/GO_0047012) (sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0016791](http://purl.obolibrary.org/obo/GO_0016791) (phosphatase activity), [GO:0035855](http://purl.obolibrary.org/obo/GO_0035855) (megakaryocyte development), [GO:0003906](http://purl.obolibrary.org/obo/GO_0003906) (DNA-(apurinic or apyrimidinic site) lyase activity), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0014911](http://purl.obolibrary.org/obo/GO_0014911) (positive regulation of smooth muscle cell migration), [GO:0016311](http://purl.obolibrary.org/obo/GO_0016311) (dephosphorylation), [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0007169](http://purl.obolibrary.org/obo/GO_0007169) (transmembrane receptor protein tyrosine kinase signaling pathway), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0006629](http://purl.obolibrary.org/obo/GO_0006629) (lipid metabolic process), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0030036](http://purl.obolibrary.org/obo/GO_0030036) (actin cytoskeleton organization), [GO:0010564](http://purl.obolibrary.org/obo/GO_0010564) (regulation of cell cycle process), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye), [GO:0061056](http://purl.obolibrary.org/obo/GO_0061056) (sclerotome development), [GO:0035441](http://purl.obolibrary.org/obo/GO_0035441) (cell migration involved in vasculogenesis), [GO:0014068](http://purl.obolibrary.org/obo/GO_0014068) (positive regulation of phosphatidylinositol 3-kinase signaling), [GO:0033144](http://purl.obolibrary.org/obo/GO_0033144) (negative regulation of intracellular steroid hormone receptor signaling pathway), [GO:0050839](http://purl.obolibrary.org/obo/GO_0050839) (cell adhesion molecule binding), [GO:0048514](http://purl.obolibrary.org/obo/GO_0048514) (blood vessel morphogenesis), [GO:0004930](http://purl.obolibrary.org/obo/GO_0004930) (G-protein coupled receptor activity), [GO:0032967](http://purl.obolibrary.org/obo/GO_0032967) (positive regulation of collagen biosynthetic process), [GO:0004935](http://purl.obolibrary.org/obo/GO_0004935) (adrenergic receptor activity), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0035793](http://purl.obolibrary.org/obo/GO_0035793) (positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway), [GO:0035791](http://purl.obolibrary.org/obo/GO_0035791) (platelet-derived growth factor receptor-beta signaling pathway), [GO:0006695](http://purl.obolibrary.org/obo/GO_0006695) (cholesterol biosynthetic process), [GO:0006696](http://purl.obolibrary.org/obo/GO_0006696) (ergosterol biosynthetic process), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0006694](http://purl.obolibrary.org/obo/GO_0006694) (steroid biosynthetic process), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0009967](http://purl.obolibrary.org/obo/GO_0009967) (positive regulation of signal transduction), [GO:0040008](http://purl.obolibrary.org/obo/GO_0040008) (regulation of growth), [GO:0048407](http://purl.obolibrary.org/obo/GO_0048407) (platelet-derived growth factor binding), [GO:0045931](http://purl.obolibrary.org/obo/GO_0045931) (positive regulation of mitotic cell cycle), [GO:0031748](http://purl.obolibrary.org/obo/GO_0031748) (D1 dopamine receptor binding), [GO:0003854](http://purl.obolibrary.org/obo/GO_0003854) (3-beta-hydroxy-delta5-steroid dehydrogenase activity), [GO:0032956](http://purl.obolibrary.org/obo/GO_0032956) (regulation of actin cytoskeleton organization), [GO:2000648](http://purl.obolibrary.org/obo/GO_2000648) (positive regulation of stem cell proliferation), [GO:0071880](http://purl.obolibrary.org/obo/GO_0071880) (adenylate cyclase-activating adrenergic receptor signaling pathway), [GO:0035789](http://purl.obolibrary.org/obo/GO_0035789) (metanephric mesenchymal cell migration), [GO:0004709](http://purl.obolibrary.org/obo/GO_0004709) (MAP kinase kinase kinase activity), [GO:0016126](http://purl.obolibrary.org/obo/GO_0016126) (sterol biosynthetic process), [GO:0043406](http://purl.obolibrary.org/obo/GO_0043406) (positive regulation of MAP kinase activity), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0007191](http://purl.obolibrary.org/obo/GO_0007191) (adenylate cyclase-activating dopamine receptor signaling pathway), [GO:0040014](http://purl.obolibrary.org/obo/GO_0040014) (regulation of multicellular organism growth), [GO:0090276](http://purl.obolibrary.org/obo/GO_0090276) (regulation of peptide hormone secretion), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060548](http://purl.obolibrary.org/obo/GO_0060548) (negative regulation of cell death), [GO:0060428](http://purl.obolibrary.org/obo/GO_0060428) (lung epithelium development), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0040018](http://purl.obolibrary.org/obo/GO_0040018) (positive regulation of multicellular organism growth), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis), [GO:0050730](http://purl.obolibrary.org/obo/GO_0050730) (regulation of peptidyl-tyrosine phosphorylation), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0016477](http://purl.obolibrary.org/obo/GO_0016477) (cell migration), [GO:0031852](http://purl.obolibrary.org/obo/GO_0031852) (mu-type opioid receptor binding), [GO:2000773](http://purl.obolibrary.org/obo/GO_2000773) (negative regulation of cellular senescence), [GO:0016579](http://purl.obolibrary.org/obo/GO_0016579) (protein deubiquitination), [GO:0038127](http://purl.obolibrary.org/obo/GO_0038127) (ERBB signaling pathway), [GO:0046488](http://purl.obolibrary.org/obo/GO_0046488) (phosphatidylinositol metabolic process), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0042445](http://purl.obolibrary.org/obo/GO_0042445) (hormone metabolic process), [GO:0090280](http://purl.obolibrary.org/obo/GO_0090280) (positive regulation of calcium ion import), [GO:0001894](http://purl.obolibrary.org/obo/GO_0001894) (tissue homeostasis), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0021514](http://purl.obolibrary.org/obo/GO_0021514) (ventral spinal cord interneuron differentiation), [GO:0005158](http://purl.obolibrary.org/obo/GO_0005158) (insulin receptor binding), [GO:0060842](http://purl.obolibrary.org/obo/GO_0060842) (arterial endothelial cell differentiation), [GO:0005159](http://purl.obolibrary.org/obo/GO_0005159) (insulin-like growth factor receptor binding), [GO:0009755](http://purl.obolibrary.org/obo/GO_0009755) (hormone-mediated signaling pathway), [GO:0032528](http://purl.obolibrary.org/obo/GO_0032528) (microvillus organization), [GO:0072262](http://purl.obolibrary.org/obo/GO_0072262) (metanephric glomerular mesangial cell proliferation involved in metanephros development), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0001588](http://purl.obolibrary.org/obo/GO_0001588) (dopamine neurotransmitter receptor activity, coupled via Gs), [GO:0043274](http://purl.obolibrary.org/obo/GO_0043274) (phospholipase binding), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0055003](http://purl.obolibrary.org/obo/GO_0055003) (cardiac myofibril assembly), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016853](http://purl.obolibrary.org/obo/GO_0016853) (isomerase activity), [GO:0031434](http://purl.obolibrary.org/obo/GO_0031434) (mitogen-activated protein kinase kinase binding), [GO:0031313](http://purl.obolibrary.org/obo/GO_0031313) (extrinsic component of endosome membrane), [GO:0048609](http://purl.obolibrary.org/obo/GO_0048609) (multicellular organismal reproductive process), [GO:0005161](http://purl.obolibrary.org/obo/GO_0005161) (platelet-derived growth factor receptor binding), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0021865](http://purl.obolibrary.org/obo/GO_0021865) (symmetric radial glial cell division in forebrain), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0046426](http://purl.obolibrary.org/obo/GO_0046426) (negative regulation of JAK-STAT cascade), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development), [GO:0035909](http://purl.obolibrary.org/obo/GO_0035909) (aorta morphogenesis), [GO:0032516](http://purl.obolibrary.org/obo/GO_0032516) (positive regulation of phosphoprotein phosphatase activity), [GO:0005834](http://purl.obolibrary.org/obo/GO_0005834) (heterotrimeric G-protein complex), [GO:0007219](http://purl.obolibrary.org/obo/GO_0007219) (Notch signaling pathway), [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0010863](http://purl.obolibrary.org/obo/GO_0010863) (positive regulation of phospholipase C activity), [GO:0050921](http://purl.obolibrary.org/obo/GO_0050921) (positive regulation of chemotaxis), [GO:0030335](http://purl.obolibrary.org/obo/GO_0030335) (positive regulation of cell migration), [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0005017](http://purl.obolibrary.org/obo/GO_0005017) (platelet-derived growth factor-activated receptor activity), [GO:0060501](http://purl.obolibrary.org/obo/GO_0060501) (positive regulation of epithelial cell proliferation involved in lung morphogenesis), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0009968](http://purl.obolibrary.org/obo/GO_0009968) (negative regulation of signal transduction), [GO:0005925](http://purl.obolibrary.org/obo/GO_0005925) (focal adhesion), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0051463](http://purl.obolibrary.org/obo/GO_0051463) (negative regulation of cortisol secretion), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0033277](http://purl.obolibrary.org/obo/GO_0033277) (abortive mitotic cell cycle), [GO:0017124](http://purl.obolibrary.org/obo/GO_0017124) (SH3 domain binding), [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development), [GO:2000573](http://purl.obolibrary.org/obo/GO_2000573) (positive regulation of DNA biosynthetic process), [GO:0035335](http://purl.obolibrary.org/obo/GO_0035335) (peptidyl-tyrosine dephosphorylation), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0021846](http://purl.obolibrary.org/obo/GO_0021846) (cell proliferation in forebrain), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006470](http://purl.obolibrary.org/obo/GO_0006470) (protein dephosphorylation), [GO:0060613](http://purl.obolibrary.org/obo/GO_0060613) (fat pad development), [GO:0048745](http://purl.obolibrary.org/obo/GO_0048745) (smooth muscle tissue development), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0060612](http://purl.obolibrary.org/obo/GO_0060612) (adipose tissue development), [GO:0005811](http://purl.obolibrary.org/obo/GO_0005811) (lipid droplet), [GO:0005019](http://purl.obolibrary.org/obo/GO_0005019) (platelet-derived growth factor beta-receptor activity), [GO:0004721](http://purl.obolibrary.org/obo/GO_0004721) (phosphoprotein phosphatase activity), [GO:0000252](http://purl.obolibrary.org/obo/GO_0000252) (C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity), [GO:0003755](http://purl.obolibrary.org/obo/GO_0003755) (peptidyl-prolyl cis-trans isomerase activity), [GO:0004726](http://purl.obolibrary.org/obo/GO_0004726) (non-membrane spanning protein tyrosine phosphatase activity), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0004725](http://purl.obolibrary.org/obo/GO_0004725) (protein tyrosine phosphatase activity), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0072277](http://purl.obolibrary.org/obo/GO_0072277) (metanephric glomerular capillary formation), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 56.23%
- [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number) 50.53%
- [GO:0097150](http://purl.obolibrary.org/obo/GO_0097150) (neuronal stem cell population maintenance) 50.53%
- [GO:0071670](http://purl.obolibrary.org/obo/GO_0071670) (smooth muscle cell chemotaxis) 50.53%
- [GO:0061300](http://purl.obolibrary.org/obo/GO_0061300) (cerebellum vasculature development) 50.53%
- [GO:0061298](http://purl.obolibrary.org/obo/GO_0061298) (retina vasculature development in camera-type eye) 50.53%
- [GO:0060981](http://purl.obolibrary.org/obo/GO_0060981) (cell migration involved in coronary angiogenesis) 50.53%
- [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development) 50.53%
- [GO:0060716](http://purl.obolibrary.org/obo/GO_0060716) (labyrinthine layer blood vessel development) 50.53%
- [GO:0060674](http://purl.obolibrary.org/obo/GO_0060674) (placenta blood vessel development) 50.53%
- [GO:0060437](http://purl.obolibrary.org/obo/GO_0060437) (lung growth) 50.53%
- [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development) 50.53%
- [GO:0036302](http://purl.obolibrary.org/obo/GO_0036302) (atrioventricular canal development) 50.53%
- [GO:0035907](http://purl.obolibrary.org/obo/GO_0035907) (dorsal aorta development) 50.53%
- [GO:0035904](http://purl.obolibrary.org/obo/GO_0035904) (aorta development) 50.53%


